What are the side effects and difficulties with new myeloma immune therapies?

In this week's "Ask Dr. Durie" myeloma expert Dr. Brian G.M. Durie discusses CAR T-cell therapy and bispecific monoclonal antibodies and their potential side effects such as immune suppression, increased risk of infection, fatigue, and reduced blood counts.

The BOTTOM LINE: Myeloma patients should weigh the benefits and potential risks of new immune therapies, considering access, side effects, and alternative treatment options, to make well-informed decisions about their treatment journey.
_______________
Improving Lives | Finding the Cure

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Subscribe to our channel:    / imfmyeloma  

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: @myeloma |   / myeloma  
Twitter: @IMFMyeloma |   / imfmyeloma  
Instagram: @imfmyeloma |   / imfmyeloma  
LinkedIn:   / international-myeloma-foundation  

Support the IMF | Donate Now! https://secure.myeloma.org/page/40697...
Category
Nonprofits & Activism
License
Standard YouTube License

In most cases, captions are autogenerated by YouTube.